BRIEF-Keros Therapeutics Board Undertaking Formal Review Process To Evaluate Strategic Alternatives

Reuters
May 19
BRIEF-Keros <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Board Undertaking Formal Review Process To Evaluate Strategic Alternatives

May 19 (Reuters) - Keros Therapeutics Inc KROS.O:

  • KEROS THERAPEUTICS INC - BOARD UNDERTAKING FORMAL REVIEW PROCESS TO EVALUATE STRATEGIC ALTERNATIVES

Source text: ID:nGNX7JGtCR

Further company coverage: KROS.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10